FY15 turned out to be an eventful year for Sun with Ranbaxy merger, Halol compliance issues and specialty initiatives being the three key highlights, says an IIFL report.
Subscribe To Our Free Newsletter |
FY15 turned out to be an eventful year for Sun with Ranbaxy merger, Halol compliance issues and specialty initiatives being the three key highlights, says an IIFL report.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!